Literature DB >> 16556155

The impact of overweight on the development of diabetes after heart transplantation.

J Kahn1, P Rehak, M Schweiger, A Wasler, T Wascher, K H Tscheliessnigg, H Müller.   

Abstract

BACKGROUND: Overweight is defined with a body mass index (BMI) >25. A BMI >25 is known as an independent risk factor for increased morbidity and mortality. The influence of an increased BMI on the development of diabetes and on survival after heart transplantation (HTX) was investigated.
METHODS: A total of 137 patients (116 men, 21 women), who underwent HTX at our Department from 1986 to 2002, were included in the study. For group stratification, the pre-operative BMI values were taken (group I: BMI </or=25; group II: BMI > 25). Groups were compared for primary disease, age and sex, development of renal failure, development of diabetes, and survival. The probability of survival and the freedom-from-diabetes interval were calculated by the use of Kaplan-Meier method.
RESULTS: No significant differences between groups I and II were found concerning primary disease, age and sex, and occurrence of renal failure. There was a tendency towards increased survival (p = 0.18) in group I. Patients of group II developed diabetes after HTX more frequently than those of group I (p < 0.001). Cox regression revealed that pre-operative BMI >25 is a highly significant independent risk factor for post-operative development of diabetes mellitus (DM) (p < 0.001).
CONCLUSION: Overweight prior to HTX appears to negatively influence long-term survival after HTX, although this difference did not reach statistical significance. Pre-operative overweight is a significant and independent risk factor for the development of post-transplant diabetes.

Entities:  

Mesh:

Year:  2006        PMID: 16556155     DOI: 10.1111/j.1399-0012.2005.00441.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

1.  Clinical outcomes in overweight heart transplant recipients.

Authors:  Anne Jalowiec; Kathleen L Grady; Connie White-Williams
Journal:  Heart Lung       Date:  2016-04-14       Impact factor: 2.210

Review 2.  Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets.

Authors:  Luciano Potena; Hannah A Valantine
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

Review 3.  Obesity in patients with end-stage heart failure.

Authors:  Bogumiła Król; Aleksandra Oprzędkiewicz; Wioletta Szczurek; Bożena Szyguła-Jurkiewicz
Journal:  Kardiochir Torakochirurgia Pol       Date:  2018-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.